naproxen 500 MG Delayed Release Oral Tablet
naproxen
RxCUI: 311915
What the CMS Formulary Data Shows for naproxen 500 MG Delayed Release Oral Tablet
Per the CMS 2026 Part D formulary file, naproxen 500 MG Delayed Release Oral Tablet (RxNorm concept RXCUI 311915, generic name naproxen) appears on 172 distinct formulary files spanning 2,791 Medicare Part D plan offerings - 55.1% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.2.
Real-world access to naproxen 500 MG Delayed Release Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 30.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,344,536 Part D beneficiaries filled naproxen 500 MG Delayed Release Oral Tablet in 2023, with total plan-and-beneficiary spending of $48,825,410 and an average per-beneficiary annual cost of $36.31. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry naproxen 500 MG Delayed Release Oral Tablet today.
Coverage Details
- Formularies covering
- 172
- Plans covering
- 2,791
- Coverage rate
- 55.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 30.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,344,536
- Total spending
- $48,825,410
- Avg per beneficiary
- $36.31
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering naproxen 500 MG Delayed Release Oral Tablet
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering naproxen 500 MG Delayed Release Oral Tablet
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is naproxen 500 MG Delayed Release Oral Tablet covered by Medicare Part D?
Yes, naproxen 500 MG Delayed Release Oral Tablet is covered by 2,791 Medicare Part D plans (55.1% of all Part D formularies).
What tier is naproxen 500 MG Delayed Release Oral Tablet on Medicare Part D plans?
naproxen 500 MG Delayed Release Oral Tablet averages Tier 2.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does naproxen 500 MG Delayed Release Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for naproxen 500 MG Delayed Release Oral Tablet. Step therapy: 0%. Quantity limits: 30.2%.
How much does Medicare spend on naproxen 500 MG Delayed Release Oral Tablet?
In 2023, total Medicare Part D spending on naproxen 500 MG Delayed Release Oral Tablet was $48,825,410, covering 1,344,536 beneficiaries. The average spend per beneficiary was $36.31.
Read our methodology - how this data is sourced, computed, and verified.